Cure My Disease

Don't miss your cure!

 Log in / Sign up

Massive sepsis study could revolutionize ICU care

NCT ID NCT07707622

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: Beijing Chao Yang Hospital Source: ClinicalTrials.gov ↗

First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This study follows 2,400 critically ill patients in intensive care units across China to better understand sepsis, a life-threatening condition where the body's response to infection damages its own organs. Researchers will collect detailed data on infections, immune responses, and patient outcomes to develop tools for earlier detection and more personalized treatment. The goal is to reduce deaths and improve recovery for the millions affected by sepsis worldwide.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could lead to better early warning systems and personalized treatments for sepsis, potentially saving thousands of lives in intensive care units.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly test a new drug or therapy. The findings may take years to translate into clinical practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEPSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

infectious disease with sepsis Sepsis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SEPSIS

Contacts and locations

Locations

  • Beijing Chao Yang Hospital

    Beijing, 100020, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.